S. Walker

发表

Determinants of response to first HAART regimen in antiretroviral‐naïve patients with an estimated time since HIV seroconversion

H. Jacqmin-Gadda, C. Sabin, F. Dabis, 2006, HIV medicine.

Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial.

P. Kaleebu, A. Siika, B. Castelnuovo, 2022, The lancet. HIV.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Impact of Cotrimoxazole on Carriage and Antibiotic Resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-Infected Children in Zambia

J. Mwansa, S. Gillespie, D. Gibb, 2010, Antimicrobial Agents and Chemotherapy.

A Qualitative Study to Identify Perceptual Barriers to Antiretroviral Therapy (ART) Uptake and Adherence in HIV Positive People from UK Black African and Caribbean Communities

Jonathan A. Smith, R. Horne, S. Michie, 2019, AIDS and Behavior.

Clinical Differences between Younger and Older Adults with HIV/AIDS Starting Antiretroviral Therapy in Uganda and Zimbabwe: A Secondary Analysis of the DART Trial

Sujal M. Parikh, A. Semeere, C. Kityo, 2013, PloS one.

Response to combination antiretroviral therapy: variation by age

A. d’Arminio Monforte, C. Sabin, M. Battegay, 2008, AIDS.

Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks.

Anne M Johnson, V. Beral, J. Kaldor, 2002, International journal of epidemiology.

Plasma Pharmacokinetics of Once- versus Twice-Daily Lamivudine and Abacavir: Simplification of Combination Treatment in HIV-1-Infected Children (Penta-13)

S. Khoo, D. Gibb, H. Lyall, 2005, Antiviral therapy.

Antiretroviral therapy for HIV‐infected children

M. Sharland, D. Gibb, K. Doerholt, 2004 .

Anthropometric Measurements and Lipid Profiles to Detect Early Lipodystrophy in Antiretroviral Therapy Experienced HIV-Infected Children in the Chapas-3 Trial

N. Klein, V. Mulenga, D. Gibb, 2014, Antiviral therapy.

Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy

C. Sabin, V. Rondeau, M. Prins, 2009, AIDS.

Maintaining the nelfinavir trough concentration above 0.8 mg/L improves virologic response in HIV-1-infected children.

D. Gibb, R. de Groot, R. Hoetelmans, 2004, The Journal of pediatrics.

Pharmacokinetics of nevirapine in HIV-infected children with and without malnutrition receiving divided adult fixed-dose combination tablets.

S. Khoo, W. Fraser, D. Back, 2009, The Journal of antimicrobial chemotherapy.

Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates

N. Pantazis, A. Hatzakis, G. Touloumi, 2004, AIDS.

High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy

A. Breckenridge, P. Kaleebu, D. Pillay, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Highly Active Antiretroviral Therapy Interruption: Predictors and Virological and Immunologic Consequences

N. Pantazis, H. Stirnadel, G. Touloumi, 2006, Journal of acquired immune deficiency syndromes.

Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion

Kholoud Porter, Maria Prins, Caroline Sabin, 2006, AIDS.

Clinically-driven monitoring of children on ART is safe and may increase access to treatment

D. Gibb, A. Kekitiinwa, A. South, 2013 .

Survival and Causes of Death, 2 years after introduction of Antiretroviral Therapy in Africa: a historical cohort comparison in Entebbe, Uganda

N. French, C. Gilks, J. Nakiyingi, 2006 .

Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

B. Gazzard, C. Leen, C. Sabin, 2008, Journal of acquired immune deficiency syndromes.

Lack of minority K65R-resistant viral populations detected after repeated treatment interruptions of tenofovir/zidovudine and lamivudine in a resource-limited setting.

D. Pillay, C. Gilks, P. Katundu, 2010, Journal of acquired immune deficiency syndromes.

CD8+ T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4+ T Cells <200 Cell/μL: The DART Trial STI Substudy

P. Kaleebu, C. Gilks, F. Gotch, 2011, AIDS research and treatment.

Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study

W. Tinago, C. Gilks, E. Katabira, 2014, AIDS Research and Therapy.

Neurocognitive Function at the First-Line Failure and on the Second-Line Antiretroviral Therapy in Africa: Analyses From the EARNEST Trial

A. Kambugu, J. V. van Oosterhout, N. Paton, 2016, Journal of acquired immune deficiency syndromes.

Effect of concurrent zidovudine use on the resistance pathway selected by abacavir‐containing regimens

D. Gibb, D. Irlbeck, M. Ait-Khaled, 2004, HIV medicine.

The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains

D. Pillay, P. Cane, C. Parry, 2011, Retrovirology.

Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV

L. Shaw, S. Walker, E. Lhomme, 2020 .

Impact of routine laboratory monitoring over 5 years after antiretroviral therapy (ART)initiation on clinical disease progression of HIV-infected African adults: the DART Trial finalresults

C. Gilks, J. Darbyshire, E. Katabira, 2009 .

Cost Effectiveness Analysis of Routine Laboratory or Clinically Driven Strategies for Monitoring Anti-Retroviral Therapy in Uganda and Zimbabwe (DART Trial)

C. Gilks, J. Darbyshire, J. Kigozi, 2009 .

Clustering based on adherence data

Hannu Oja, Pauliina Ilmonen, Sylvia Kiwuwa-Muyingo, 2011, Epidemiologic perspectives & innovations : EP+I.

Impact of Cotrimoxazole on Carriage and Antibiotic Resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-Infected Children in Zambia

J. Mwansa, S. Gillespie, D. Gibb, 2010, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics and pharmacodynamics of azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a protocol for a Phase II randomised controlled trial

T. Williams, D. Gibb, K. Maitland, 2021, Wellcome open research.

Prices, Diagnostic Tests and the Demand for Malaria Treatment:

Justin M. Cohen, Simone Schaner, Jessica L. Cohen, 2010 .